Plaque psoriasis and morphea in a patient on ustekinumab: A case report

被引：4
作者：
Cirone, Katrina [1 ]
Vender, Ronald [2 ,3 ,4 ]
机构：
[1] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] Dermatrials Res Inc, Hamilton, ON, Canada
[4] Dermatrials Res Inc, 707-25 Charlton Ave East, Hamilton, ON L8N 1Y2, Canada
来源：
SAGE OPEN MEDICAL CASE REPORTS | 2023年 / 11卷
关键词：
Psoriasis; morphea; ustekinumab; INTERLEUKIN-17; DISORDERS;
D O I：
10.1177/2050313X231164207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A large number of autoimmune and fibrosing conditions associated with psoriasis and morphea have been reported in the literature. Currently, the relationship between psoriasis and morphea is unknown, and the coexistence of these conditions is quite rare. Due to the few patients affected by both conditions, and the lack of knowledge concerning their pathogenic mechanisms, the cause behind this co-occurrence is poorly understood. Here, we present a case of morphea under a plaque of psoriasis in a patient managed on ustekinumab.
引用
收藏
页数：4
相关论文
共 18 条
  • [1] Current status and future prospects for biologic treatments of psoriasis
    Cline, Abigail
    Hill, Dane
    Lewallen, Robin
    Feldman, Steven R.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (12) : 1273 - 1287
  • [2] Magaña OC, 2017, ACTAS DERMO-SIFILOGR, V108, P487, DOI 10.1016/j.ad.2016.11.005
  • [3] Update on morphea Part I. Epidemiology, clinical presentation, and pathogenesis
    Fett, Nicole
    Werth, Victoria P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : 217 - 228
  • [4] Cutaneous lupus erythematosus, morphea profunda and psoriasis: A case report
    Garcia-Arpa, Monica
    Flores-Terry, Miguel A.
    Ramos-Rodriguez, Claudia
    Franco-Munoz, Monserrat
    Gonzalez-Ruiz, Lucia
    Aurelio Ramirez-Huaranga, Marco
    [J]. REUMATOLOGIA CLINICA, 2020, 16 (02): : 180 - 182
  • [5] Psoriasis and autoimmune disorders: A review of the literature
    Hsu, Leon N.
    Armstrong, April W.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (05) : 1076 - 1079
  • [6] Leitenberger JJ, 2009, ARCH DERMATOL, V145, P545, DOI 10.1001/archdermatol.2009.79
  • [7] Morphea in a Crohn's disease patient undergoing ustekinumab treatment
    Makihara-Inukai, Misako
    Takeichi, Takuya
    Ogawa-Momohara, Mariko
    Muro, Yoshinao
    Akiyama, Masashi
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (01) : 96 - 97
  • [8] Development of morphea in patients receiving biologic therapies: A systematic review
    Maliyar, Khalad
    Mufti, Asfandyar
    Sachdeva, Muskaan
    Lytvyn, Yuliya
    Salsberg, Jennifer
    Yeung, Jensen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) : 1081 - 1085
  • [9] Nilgun Bilen RA., 2006, J EUR ACAD DERMATOL, V13, P113
  • [10] Tumor necrosis factor-α inhibitor-induced morphea and psoriasiform dermatitis in a pediatric patient with Crohn's disease
    Reinhart, Jacob P.
    Aird, Jenna L.
    Stephens, Michael C.
    Asch, Sarah
    Orandi, Amir B.
    Tollefson, Megha M.
    [J]. PEDIATRIC DERMATOLOGY, 2023, 40 (03) : 519 - 522
12